PCV43 MODELED COST-EFFECTIVENESS OF ACHIEVING MULTIPLE LIPID TARGETSWHEN FENOFIBRIC ACID IS CO-ADMINISTERED WITH SIMVASTATIN, ROSUVASTATIN, AND ATORVASTATIN
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66341-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)66341-3/fulltext
Section Title :
Section Order :
178
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66341-3&doi=10.1016/S1098-3015(10)66341-3